Bruce Ovbiagele – författare
1 324 kr
Skickas inom 10-15 vardagar
1 544 kr
Skickas inom 10-15 vardagar
1 950 kr
Läs direkt efter köp
This second edition updates established evidence for contemporary management of ischemic stroke. Therapeutics for acute management, secondary prevention, recovery, rehabilitation, asymptomatic cerebral ischemia, special populations, and implementation of stroke systems of care are all discussed.
Chapters are authored by leading academicians from around the world with real-world clinical practice experience, and comprise the scientific rationale and expert consensus recommendations, which underlie prevailing (and possibly future) therapeutic strategies for managing ischemic cerebrovascular disease. New chapter topics include neuroprotectants, treatment of the oldest old, brain-computer interfaces, disparities, and the global burden.
The specialist or general practitioner will gain critical knowledge in stroke management, current clinical challenges and promising new therapies under investigation.
1 105 kr
Skickas inom 10-15 vardagar
1 544 kr
Skickas inom 10-15 vardagar
1 950 kr
Läs direkt efter köp
The recent high-profile murders of George Floyd, and other African American individuals, along with the prevailing coronavirus disease (COVID-19) pandemic have reinforced the notion that certain marginalized populations have worse health outcomes than other populations, likely due to unequal and unjust policies and practices.
Neurological processes and prognoses frequently vary by sex/gender, race/ethnicity, socioeconomic status, and geographic location. In particular, individuals of lower socioeconomic status and from minority racial and ethnic backgrounds have worse neurological health and often receive a lower standard of neurological care. These inequities in neurological outcomes are attributed to wider societal social influences, which impact how people live and how neurology is practiced.
Published evidence suggests that healthcare providers and the healthcare system contribute to inequities in neurological care for vulnerable and underserved populations. However, educating neurology care providers about these issues and training them to provide equitable care for these patients can potentially improve neurology care access, delivery, and outcomes.
In this book we provide the theoretical background, scientific evidence, and experiential knowledge warranted to properly care for vulnerable, underserved patients with neurological diseases at the levels of the provider and system. This book examines the root causes of neurological health inequities across a broad range of topics and offers possible solutions for achieving neurological health equity. Initial chapters help to frame the overall issue of neurological health equity. Subsequent chapters evaluate neurological health equity from the clinical practice standpoint, with a focus on select populations and subspecialty care delivery settings. Lastly, we discuss the bigger picture with regard to the pipeline of practitioners and purview of policy makers.
This text is relevant for neurology residents and fellows, multidisciplinary neurological care practitioners (neurologists, neurosurgeons, advanced practice providers, hospitalists, emergency physicians, critical care physicians, pharmacists, and allied health personnel), and public health researchers and health policy makers.
The book is divided into three sections: Principles, Neurological Conditions, and Priorities. The first section establishes the framework and explains various key terminologies and concepts, which undergird the care of vulnerable and undeserved patient populations. The second section, Neurological Conditions, covers key neurological diseases by sub-specialty describing published evidence of care and outcome disparities, gaps in knowledge, practical techniques for bridging these disparities on provider and system levels. The third section, Priorities, identifies important areas of focus and improvement targeting trainees, researchers, community partners, stakeholder organizations and policy makers, which would be crucial for implementing sustained societal-level enhancements in the neurological health of these vulnerable populations.
1 292 kr
Läs direkt efter köp
This complete resource captures state-of-the-art strategies and the accelerated pace of discovery that is revolutionizing what is known about ischemic stroke and its treatment. Therapeutics for acute management, secondary prevention, recovery, rehabilitation, asymptomatic cerebral ischemia, and implementation of stroke systems of care are all discussed in this comprehensive yet practical guide. Chapters are authored by leading academicians with extensive clinical practice experience from all over the world and feature the scientific evidence behind prevailing therapeutic strategies for managing ischemic cerebrovascular disease. The specialist or general practitioner will gain critical knowledge in stroke management, current clinical challenges and promising new therapies under investigation.
1 105 kr
Skickas inom 10-15 vardagar
1 459 kr
Läs direkt efter köp
This book provides a framework for goal-targeted management of the adult patient with spontaneous non-traumatic intracerebral hemorrhage (ICH). Topics addressed in a comprehensive yet practical manner in the book include pre-hospital/emergency department care, early inpatient work-up, antithrombotic- and thrombolytic-related strokes, optimal blood pressure management, avoidance of medical complications, surgical interventions, outcome prognostication, recurrence prevention, rehabilitation/recovery, special situations, systems of care, and the design of clinical trials for patients with ICH. Procedures, processes, and helpful decision-making algorithms are presented with the aid of complementary illustrations that facilitate understanding of practical aspects and enable the reader to promptly retrieve relevant information. In addition, the most current evidence-based therapies for routine management of ICH patients and a glimpse of promising future treatment strategies are reviewed.Timely and consolidated, clinicians will find this to be an indispensable resource to navigating the ever-increasing pace of discovery that is transforming what we know about ICH and its treatment.